split-banner-image

ANZ 8101

Closed

ANZ 8101

BCT Study Chair:

Alan Coates

Phase III trial to evaluate continuous versus intermittent combination chemotherapy in advanced breast cancer.

international

0

INTERNATIONAL

Total number of trial

participants internationally

australia & new zealand

308

AUSTRALIA & NEW ZEALAND

Total number of trial participants

in Australia and New Zealand

institutions

12

INSTITUTIONS

Total number of participating institutions

in Australia and New Zealand

ANZ 8101 PUBLICATIONS

2011

A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer.

Lee CK, Hudson M, Stockler M, Coates AS, Ackland S, Gebski V, Lord S, Friedlander M, Boyle F, Simes RJ. Breast Cancer Res Treat. 2011; 129(2):467-476, Journal

2010

Historical cross-trial comparisons for competing treatments in advanced breast cancer – an empirical analysis of bias.

Lee CK, Lord SJ, Stockler MR, Coates AS, Gebski V, Simes RJ. Eur J Cancer 2010; 46541-548, Journal

Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer.

Lee CK, Stockler MR, Coates AS, Gebski V, Lord SJ, Simes RJ on behalf of Australian New Zealand Breast Cancer Trials Group. Br J Cancer 2010; 102(9):1341-1347, Journal

2009

Historical cross-trial comparisons for competing treatments in advanced breast cancer – an empirical analysis of bias.

Lee CK, Lord SJ, Stockler MR, Gebski V, Coates AS, Simes RJ, on behalf of Australian and New Zealand Breast Cancer Trials Group (ANZ BCTG). ASBD 2009; Abstract

Predicting survival time in women starting first line chemotherapy for advanced breast cancer.

Lee CK, Stockler MR, Hudson M, Coates AS, Gebski V, Lord SJ, Simes RJ, on behalf of Australian New Zealand Breast Cancer Trials Group. SABCS 2009; 4066, Poster

Outcomes of first line chemotherapy for advanced breast cancer in women with good versus poor quality of life at baseline.

Lee C, Stockler M, Gebski V, Coates AS, Simes RJ, on behalf of Australian and Newzealand Breast Cancer Trials Group (ANZ BCTG)& NHMRC Clinical Trials Centre. ASCO 2009; 1036, Abstract

LOAD MORE

Institutions